Log In
Print this Print this

Trisomy 21 test (PraenaTest)

  Manage Alerts
Collapse Summary General Information
Company GATC Biotech AG
DescriptionNon-invasive prenatal diagnostic
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect fetal trisomy 21 in maternal blood; Detects fetal trisomies 13, 18 and 21 as well as gonosomal aneuploidy from maternal blood
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today